Literature DB >> 28857203

Assessment of alternative emergency treatments for symptomatic irreversible pulpitis: a randomized clinical trial.

B Eren1, E O Onay1, M Ungor1.   

Abstract

AIM: To evaluate three emergency procedures for their ability to alleviate clinical symptoms associated with symptomatic teeth having signs of (at least) partial irreversible pulpitis.
METHODOLOGY: Sixty-six maxillary and mandibular molars were randomly assigned to a total pulpectomy group (TP; n = 22), partial pulpectomy group (PP; n = 22) or pulpotomy group (P; n = 22). Procedure durations were recorded. Patients answered a questionnaire on daily analgesic requirements and about clinical symptoms (pain intensity, chewing sensitivity and thermal sensitivity) after the anaesthetic effect had disappeared (Day 0) and on Days 1, 3 and 7 post-treatment.
RESULTS: The total pulpectomy group was associated with the longest procedures (median, 24 min), followed by the partial pulpectomy and pulpotomy groups (P < 0.001 for all). In all three groups, pain intensity, thermal sensitivity and chewing sensitivity decreased significantly from the preoperative time-point to Day 7 (P < 0.001 for all). The total pulpectomy group reported greater reductions in pain intensity than the pulpotomy group between Days 0 and 7, Days 1 and 3, and Days 1 and 7 (P < 0.001 for all). No other intergroup differences were noted regarding reductions in pain intensity, and none were observed with respect to changes in prevalence of thermal sensitivity and chewing sensitivity. There were also no significant intergroup differences regarding the analgesic requirements throughout the 7 days.
CONCLUSION: As emergency treatments for teeth having signs of irreversible pulpitis, pulpotomy, partial pulpectomy and total pulpectomy were comparable with respect to relieving clinical symptoms. Pulpotomy may be preferred because it requires significantly less time and is a simple technique that relieves symptoms quickly and effectively.
© 2017 International Endodontic Journal. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  emergency treatment; endodontics; irreversible pulpitis; pain; pulpotomy; treatment modalities

Mesh:

Year:  2017        PMID: 28857203     DOI: 10.1111/iej.12851

Source DB:  PubMed          Journal:  Int Endod J        ISSN: 0143-2885            Impact factor:   5.264


  6 in total

Review 1.  Coronavirus Disease 19 (COVID-19): Implications for Clinical Dental Care.

Authors:  Amber Ather; Biraj Patel; Nikita B Ruparel; Anibal Diogenes; Kenneth M Hargreaves
Journal:  J Endod       Date:  2020-04-06       Impact factor: 4.171

2.  Aerosols Generated during Endodontic Treatment: A Special Concern during the Coronavirus Disease 2019 Pandemic.

Authors:  Mason Bahador; Rayyan A Alfirdous; Theeb A Alquria; Ina L Griffin; Patricia A Tordik; Frederico C Martinho
Journal:  J Endod       Date:  2021-02-03       Impact factor: 4.171

3.  Short-Term Pain Evolution and Treatment Success of Pulpotomy as Irreversible Pulpitis Permanent Treatment: A Non-Randomized Clinical Study.

Authors:  Julien Beauquis; Hugo M Setbon; Charles Dassargues; Pierre Carsin; Sam Aryanpour; Jean-Pierre Van Nieuwenhuysen; Julian G Leprince
Journal:  J Clin Med       Date:  2022-01-31       Impact factor: 4.241

4.  Outcomes to evaluate care for adults with acute dental pain and infection: a systematic narrative review.

Authors:  Wendy Thompson; Shaun Howe; Carole Pitkeathley; Carly Coull; L Teoh
Journal:  BMJ Open       Date:  2022-02-21       Impact factor: 2.692

5.  To Drill or not to Drill: A Turnabout in Endodontic Practices during Corona Virus Disease -2019- A South India Based Study.

Authors:  M S Ravisankar; K S Arya; Faisal Ma Gaffoor; Sunil John; C Sabari Girish; Ashitha Aravindan
Journal:  J Pharm Bioallied Sci       Date:  2022-07-13

6.  To Drill or Not to Drill: Management of Endodontic Emergencies and In-Process Patients during the COVID-19 Pandemic.

Authors:  Biraj Patel; Michael A Eskander; Nikita B Ruparel
Journal:  J Endod       Date:  2020-08-22       Impact factor: 4.171

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.